Lactic acid
- Generic Name
- Lactic acid
- Brand Names
- Dextrose and Electrolyte No. 75, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Glycerolyte 57, Ionosol-MB, Lactate 1-2-3, Lactated Ringers, Nxstage Pureflow, Physioneal 40, Plasma-lyte R, Prismasol, Ringers
- Drug Type
- Small Molecule
- Chemical Formula
- C3H6O3
- CAS Number
- 50-21-5
- Unique Ingredient Identifier
- 3B8D35Y7S4
- Background
A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed) Sodium lactate is the sodium salt of lactic acid, and has a mild saline taste. It is produced by fermentation of a sugar source, such as corn or beets, and then, by neutralizing the resulting lactic acid to create a compound having the formula NaC3H5O3.
Lactic acid was one of active ingredients in Phexxi, a non-hormonal contraceptive agent that was approved by the FDA on May 2020.
- Indication
For use as an alkalinizing agent.
- Associated Conditions
- Corns, Dehydration, Fluid Loss, Hyperkeratosis, Lichenification, Shock, Hypovolemic, Vasoplegic Shock, Verruca (Warts), Mild Metabolic acidosis, Mild, moderate Metabolic Acidosis, Moderate Metabolic acidosis
- Associated Therapies
- Chemical contraception, Electrolyte replacement, Fluid replacement therapy, Parenteral Nutrition, Peritoneal dialysis therapy, Urine alkalinization therapy
Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)
- First Posted Date
- 2016-05-18
- Last Posted Date
- 2021-11-15
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT02776488
- Locations
- 🇺🇸
David Geffen School of Medicine at UCLA, Los Angeles, California, United States
Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.
- First Posted Date
- 2008-11-02
- Last Posted Date
- 2009-03-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 31
- Registration Number
- NCT00783939
- Locations
- 🇧🇷
Sanofi-Aventis Administrative Office, Sao Paulo, Brazil
Dermacyd Femina (Lactic Acid) Pocket BR - Photo Evaluation
- First Posted Date
- 2008-11-02
- Last Posted Date
- 2008-12-19
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 27
- Registration Number
- NCT00783640
- Locations
- 🇧🇷
Sanofi-Aventis Administrative Office, Sao Paulo, Brazil
Dermacyd Breeze (Lactic Acid) Pocket BR - Compatibility
- First Posted Date
- 2008-11-02
- Last Posted Date
- 2008-12-19
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 54
- Registration Number
- NCT00784121
- Locations
- 🇧🇷
Sanofi-Aventis Administrative Office, Sao Paulo, Brazil
Dermacyd Breeze (Lactic Acid) Pocket BR - Photo Evaluation
- First Posted Date
- 2008-11-02
- Last Posted Date
- 2008-12-19
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 27
- Registration Number
- NCT00784069
- Locations
- 🇧🇷
Sanofi-Aventis Administrative Office, Sao Paulo, Brazil
Dermacyd Femina (Lactic Acid) Pocket BR - Compatibility
- First Posted Date
- 2008-11-02
- Last Posted Date
- 2008-12-19
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 54
- Registration Number
- NCT00783861
- Locations
- 🇧🇷
Sanofi-Aventis Administrative Office, Sao Paulo, Brazil
Dermacyd Teen Care Tangerina Mix - Compatibility
- Conditions
- Hygiene
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2009-05-29
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 51
- Registration Number
- NCT00761800
- Locations
- 🇧🇷
Sanofi-Aventis Administrative Office, Sao Paulo, Brazil
Acceptability of Lactacyd Femina
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2009-07-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 559
- Registration Number
- NCT00712868
- Locations
- 🇲🇽
Sanofi-Aventis Administrative Office, Col. Coyoacan, Mexico
Lactacyd Radiance (Lactic Acid) Prophetic Patch Test
- First Posted Date
- 2008-05-19
- Last Posted Date
- 2009-02-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 200
- Registration Number
- NCT00679562
- Locations
- 🇹🇭
Sanofi-Aventis Administrative Office, Bangkok, Thailand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.